Humana and Astellas Form Research Collaboration to Improve Health Care Delivery for Seniors

  Humana and Astellas Form Research Collaboration to Improve Health Care
  Delivery for Seniors

Business Wire

LOUISVILLE, Ky. & NORTHBROOK, Ill. -- February 19, 2013

Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being
companies, and Astellas Scientific and Medical Affairs Inc., a U.S. subsidiary
of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced a
multi-year research collaboration to explore new ideas and ways to improve the
health and well-being of patients and members.

The two companies will bring together researchers and health care experts from
both companies to study key issues and develop ways to reduce inefficiencies
in the management of oncology, urology and immunology conditions.

“This research collaboration will produce knowledge in important therapeutic
areas for our key population,” said William Fleming, Pharm.D., President of
Humana Pharmacy Solutions. “With about 77 percent^1 of all cancers being
diagnosed in people 55 years of age and older, and 1 in 2^2 males and 1 in 3
females at risk for developing cancer in their lifetime, this partnership will
serve to develop an important body of knowledge that will meaningfully advance
the work of our respective companies.”

“We believe that the combination of Humana’s experience with affordable senior
health care and Astellas’ commitment to advancements in healthcare,
particularly in the areas of oncology, urology and transplantation will help
improve the lifelong well-being of patients,” said Jeffrey Bloss, M.D., Vice
President, Astellas Scientific and Medical Affairs Inc. “Through this
important collaboration, we’ll use clinical data to conduct comparative
effectiveness research to evaluate ways to improve healthcare and health
outcomes for patients.”

About Humana

Humana Inc., headquartered in Louisville, Ky., is a leading health care
company that offers a wide range of insurance products and health and wellness
services that incorporate an integrated approach to lifelong well-being. By
leveraging the strengths of its core businesses, Humana believes it can better
explore opportunities for existing and emerging adjacencies in health care
that can further enhance wellness opportunities for the millions of people
across the nation with whom the company has relationships.

More information regarding Humana is available to investors via the Investor
Relations page of the company’s web site at www.humana.com, including copies
of:

  *Annual reports to stockholders
  *Securities and Exchange Commission filings
  *Most recent investor conference presentations
  *Quarterly earnings news releases
  *Replays of most recent earnings release conference calls
  *Calendar of events (including upcoming earnings conference call dates and
    times, as well as planned interaction with research analysts and
    institutional investors)
  *Corporate Governance information

About Astellas

Astellas Scientific and Medical Affairs Inc., located in Northbrook, Illinois,
is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a
pharmaceutical company dedicated to improving the health of people around the
world through the provision of innovative and reliable pharmaceutical
products. The organization is committed to becoming a global category leader
in focused areas by combining outstanding R&D and marketing capabilities. For
more information about Astellas, please visit our website at www.astellas.us.

^1
http://www.cancer.org/acs/groups/content/@corporatecommunications/documents/document/acspc-034356.pdf

^2
http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf

Contact:

Humana Corporate Communications
Alex Kepnes, 502-580-2990
akepnes@humana.com
or
Astellas Corporate Communications
Jenny Kite, 224-205-5405
jenny.kite@astellas.com
 
Press spacebar to pause and continue. Press esc to stop.